COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
出版年份 2020 全文链接
标题
COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
作者
关键词
-
出版物
Diabetes Therapy
Volume 11, Issue 6, Pages 1195-1197
出版商
Springer Science and Business Media LLC
发表日期
2020-05-07
DOI
10.1007/s13300-020-00830-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Diabetic Neuropathy Collection: Progress in Diagnosis and Screening
- (2020) Nikolaos Papanas Diabetes Therapy
- COVID-19 and diabetes: Can DPP4 inhibition play a role?
- (2020) Gianluca Iacobellis DIABETES RESEARCH AND CLINICAL PRACTICE
- Middle East respiratory syndrome
- (2020) Ziad A Memish et al. LANCET
- COVID-19 and Italy: what next?
- (2020) Andrea Remuzzi et al. LANCET
- COVID-19 and Diabetic Foot: Will the Lamp Burn Bright?
- (2020) Nikolaos Papanas et al. International Journal of Lower Extremity Wounds
- Hepatoprotective activity of metformin: A new mission for an old drug?
- (2019) Milad Iranshahy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pioglitazone ameliorates hepatic damage in irradiated rats via regulating anti-inflammatory and antifibrogenic signalling pathways
- (2019) Rasha R. Radwan et al. FREE RADICAL RESEARCH
- Therapies in non-alcoholic steatohepatitis (NASH)
- (2017) Abdul M. Oseini et al. LIVER INTERNATIONAL
- Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase
- (2017) Wei-Lun Tsai et al. Oncotarget
- Pioglitazone Enhances Cytosolic Lipolysis, β-oxidation and Autophagy to Ameliorate Hepatic Steatosis
- (2017) Pi-Jung Hsiao et al. Scientific Reports
- Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial
- (2016) Mary-Anne Doyle et al. Trials
- Pioglitazone for Hepatic Steatosis in HIV/Hepatitis C Virus Coinfection
- (2015) Lindsay Matthews et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Metformin: a cheap and well-tolerated drug that provides benefits for viral infections
- (2012) J Joven et al. HIV MEDICINE
- Pioglitazone Decreases Hepatitis C Viral Load in Overweight, Treatment Naïve, Genotype 4 Infected-Patients: A Pilot Study
- (2012) Mario Chojkier et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now